Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAccess to the study record page now displays a 403 Forbidden error, including the 403 HTML header. The previous study content is no longer accessible and has been replaced by the error page.SummaryDifference23%

- Check48 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor metadata update to the study page rather than changes to its substantive content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays a 500 server error message and HTML structure, replacing the normal study content and navigation with an error screen indicating the page is currently unavailable.SummaryDifference22%

- Check83 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, indicating a new version of the page. Substantive study details appear unchanged.SummaryDifference0.0%

- Check105 days agoChange DetectedThe page's revision tag changed from v3.6.2 to v3.6.3, indicating a minor update to the page.SummaryDifference0.0%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.